Jacob George

Title: Jacob George: Innovator in Antibody Research

Introduction

Jacob George is a prominent inventor based in Tel Aviv, Israel. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for various medical applications. With a total of 16 patents to his name, Jacob has established himself as a key figure in innovative research.

Latest Patents

Among his latest patents are the "Transthyretin antibodies and uses thereof" and "TREM2 antibodies and uses thereof." The first patent provides antibodies and antigen-binding fragments that specifically bind to human transthyretin (TTR). These anti-TTR antibodies are useful for detecting TTR and treating TTR amyloidosis in subjects. The second patent focuses on antibodies that bind to the human Triggering Receptor Expressed on Myeloid Cells 2 (TREM2). These anti-TREM2 antibodies are valuable for detecting TREM2 and treating neurodegenerative diseases.

Career Highlights

Jacob has worked with notable companies such as Vascular Biogenics Ltd. and Mor Research Applications Ltd. His work in these organizations has contributed to advancements in medical research and therapeutic development.

Collaborations

Jacob has collaborated with esteemed colleagues, including Dror Harats and Gideon Halperin. Their combined expertise has furthered the impact of their research in the field of biotechnology.

Conclusion

Jacob George is a distinguished inventor whose work in antibody research has the potential to transform medical treatments. His innovative patents and collaborations highlight his commitment to advancing healthcare solutions.